Large-scale testing (Phase 3)Study completedNCT00390533
What this trial is testing
An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder
Who this might be right for
Generalized Anxiety
Sanofi 428